Absea Biotech

A standardized framework for circulating blood proteomics - Nature Genetics The field of blood proteomics faces an upsurge of data with the challenge of cross-study comparisons. This Perspective offers an in-depth analysis and proposes reference materials to enhance data integration and accelerate clinical translation.

Papers & contact:

@natgenet.nature.com perspective: www.nature.com/articles/s41...

Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....

Interested in using N15? info@abseabio.com

New in @natgenet.nature.com: “A standardized framework for circulating blood proteomics” — co-authored by our SVP, Philip Lössl.
Recommends pooled plasma refs + isotope-labeled protein spike-ins.

Thoughts on adoption?

Learn more about👇

#Proteomics #15N #teammassspec

Day 1 at the Westlake Symposium for AI Proteomics & Virtual Cell!

Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.

Attending? Reach out, we’d love to chat!

#Proteomics #LifeSciences #Ai #teammassspec

Back-to-back proteomics in China.

After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).

Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team

Looking forward to connecting — DMs open for 1:1s!

#CNHUPO2025 #Proteomics #Biotech #Conference

Source: European Centre for Disease Prevention and Control (12-month Chikungunya virus disease case notification rate per 100 000 population, September 2024-August 2025).

ECDC: ~317,000 chikungunya cases in 2025 (Aug 2025).

Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development

Reach out for samples and technical info! 📩

#chikungunya #biotech #LifeSciences

Heads up, #Proteomics Community! 📢

We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).

Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).

Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!

Summer’s wrapping up!

Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.

Plenty of catching up, some quick decisions, and now ready for autumn experiments!

#Teamwork #AutumnVibes

Testing pan-allelic enrichment in AML PBMCs with Absea MB-081 beads.

✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.

RUO.
Contact info@abseabio.com or see datasheets on: www.absea.bio/product-deta...

@natsmb.nature.com

Mechanisms for licensing origins of DNA replication in eukaryotic cells - Nature Structural & Molecular Biology Here, the authors comprehensively discuss the different mechanisms for origin licensing in yeast and human cells. Importantly, they present intuitive videos illustrating such mechanisms with unprecede...

📢 New paper co-authored by our SAB member Bruce Stillman (cshlnews.bsky.social) in Nature SMB delves into how ORC, Cdc6, Cdt1 & MCM2-7 license DNA replication origins — tying structural and biochemical work to genome-stability implications.

Read more here: www.nature.com/articles/s41...

For research use only. Not for diagnostic use.

👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.

How do you measure “N” in the AT(N) Alzheimer’s framework? t-tau? Too much from peripheral Big-tau.
NfL? Not AD-specific.

BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.

Details below 👇

Our CEO, Tao Chen, will present “Synthetic and interaction proteomics for systems aging biology” at the Stem Cell, Aging, and Rejuvenation session — Cold Spring Harbor Asia.

🗓 Tue, Sept 16 — 19:00 CEST

Want to follow the session or connect afterward? DM us!

#proteomics #aging

MTBR-tau243 — a disease-specific Alzheimer’s biomarker that tracks NFT burden.

Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.

Connect with us or visit: www.absea.bio !

A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins Recent developments in affinity binder or mass spectrometry (MS)-based plasma proteomics are now producing panels of potential biomarker candidates for diagnosis or prognosis. However, clinical valida...

New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel).
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).

Read more here: www.mcponline.org/article/S153...

#Proteomics#MassSpec mannlab.bsky.social

Learn more: www.absea.bio/asms2025.html

#Alzheimer #Biomarkers #Neuroscience #Antibodies

For Tau research, breadth and specificity matter.

Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.

A comprehensive resource for reliable results. 
Let’s get in touch!

Ever pieced together three kits just to hit five targets? 😓.
Now imagine a single kit where you pick:
• Five validated #antibodies (10 µL each)
• One or two free 100 µL secondary antibodies
That’s our brand new Pick 5‑ #AntibodyKit —one kit, no extra orders.
Connect with us to get started!

🔗 Explore our full catalogue: www.absea.bio/index.html

Trouble with IP?

Absea’s anti-Myc/HA/FLAG magnetic beads are IP-verified and show strong signal, low background, and stable performance across tags and elution modes.

Happy to share protocols or tips—let’s connect!

#ProteinResearch #LifeScience

Super well derserved! Massive congratulations, Misha!

Speakers: Matthias @mannlab.bsky.social (@mpibiochem.bsky.social) Mikhail @savitski-lab.bsky.social (embl.org), Philip Lössl (Absea'SVP)

Grateful to everyone who joined our lunch seminar at @asbmb.bsky.social #Proteomics yesterday!

Great to connect with you and answer all your questions!

Final day today, stop by our booth on the second floor to meet our team and discuss your proteomics challenges.

We look forward to seeing you!

Nearly 24 hours to go before our first Lunch Seminar at the @asbmb.bsky.social #Proteomics meeting at @broadinstitute.org

Join ‪@savitski-lab.bsky.social as he presents on Chemical Proteomics.
🗓 Wed, Aug 20 | 12:30–2:00 PM
📍 Broad Institute Auditorium

Register here: www.absea.bio/asbmb2025.html

Last night, we welcomed members of the proteomics community for a special Absea Night ahead of the @asbmb.bsky.social #Proteomics meeting.

Great conversations, shared ideas, and plenty of smiles made it a night to remember!

Excited for the conference to officially start today!

#TeamMassSpec

✅Proteins folded
✅antibodies cleaned up
✅lunch (seminar*) prepared (signup: rb.gy/unk030, talks by @mannlab.bsky.social & @savitski-lab.bsky.social)
Our CEO Tao Chen, SVP Philip Lössl, sen scientist Marco Hennrich, and US director Ting Zhao are ready for the @asbmb.bsky.social #proteomics meeting!

Only 1 day to go till the @asbmb.bsky.social proteomics meeting at @broadinstitute.org

🚨Don’t miss Matthias Mann’s @mannlab.bsky.social plenary talk at the first-ever Absea lunch seminar on Wednesday August 20, 12:30 PM!

Secure your spot here: absea.bio/asbmb2025.html

#Proteomics #TeamMassSpec